Literature DB >> 10504502

Reduced crystallization inhibition by urine from men with nephrolithiasis.

J R Asplin1, J H Parks, M S Chen, J C Lieske, F G Toback, S N Pillay, Y Nakagawa, F L Coe.   

Abstract

BACKGROUND: Human urine is known to inhibit growth, aggregation, nucleation, and cell adhesion of calcium oxalate monohydrate (COM) crystals, the main solid phase of human kidney stones. This study tests the hypothesis that low levels of inhibition are present in men with calcium oxalate stones and could therefore promote stone production.
METHODS: In 17 stone-forming men and 17 normal men that were matched in age to within five years, we studied the inhibition by dialyzed urine proteins of COM growth, aggregation, and binding to cultured BSC-1 renal cells, as well as whole urine upper limits of metastability (ULM) for COM and calcium phosphate (CaP) in relationship to the corresponding supersaturation (SS).
RESULTS: Compared with normals, patient urine showed reduced COM growth inhibition and reduced ULM in relationship to SS. When individual defects were considered, 15 of the 17 patients were abnormal in one or more inhibition measurements. ULM and growth inhibition defects frequently coexisted.
CONCLUSIONS: Reduced COM growth and CaP and CaOx ULM values in relationship to SS are a characteristic of male stone formers. Both defects could promote stones by facilitating crystal nucleation and growth. Abnormal inhibition may be a very important cause of human nephrolithiasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504502     DOI: 10.1046/j.1523-1755.1999.00682.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  The use of risk indices: do they predict recurrence?

Authors:  Roger A L Sutton
Journal:  Urol Res       Date:  2006-01-06

2.  Probiotics for prevention of urinary stones.

Authors:  John C Lieske
Journal:  Ann Transl Med       Date:  2017-01

3.  Aggregation of freshly precipitated calcium oxalate crystals in urine of calcium stone patients and controls.

Authors:  J M Baumann; B Affolter; R Casella
Journal:  Urol Res       Date:  2011-05-13

4.  Chitosan does not reduce post-prandial urinary oxalate excretion.

Authors:  Joshua Wolf; John R Asplin; David S Goldfarb
Journal:  Urol Res       Date:  2006-02-28

5.  Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers.

Authors:  J A Wesson; V Ganne; A M Beshensky; J G Kleinman
Journal:  Urol Res       Date:  2005-04-28

6.  Gallotannin suppresses calcium oxalate crystal binding and oxalate-induced oxidative stress in renal epithelial cells.

Authors:  Hyo-Jung Lee; Soo-Jin Jeong; Moon Nyeo Park; Michael Linnes; Hee Jeoung Han; Jin Hyoung Kim; John Charles Lieske; Sung-Hoon Kim
Journal:  Biol Pharm Bull       Date:  2012       Impact factor: 2.233

Review 7.  From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis.

Authors:  Johannes M Baumann; Beat Affolter
Journal:  World J Nephrol       Date:  2014-11-06

8.  Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria.

Authors:  Deepa A Malieckal; Frank Modersitzki; Kristin Mara; Felicity T Enders; John R Asplin; David S Goldfarb
Journal:  Urolithiasis       Date:  2019-04-13       Impact factor: 3.436

9.  Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.

Authors:  Jihae Chung; Ignacio Granja; Michael G Taylor; Giannis Mpourmpakis; John R Asplin; Jeffrey D Rimer
Journal:  Nature       Date:  2016-08-17       Impact factor: 49.962

10.  Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones.

Authors:  Andrew P Evan; James E Lingeman; Elaine M Worcester; Andre J Sommer; Carrie L Phillips; James C Williams; Fredric L Coe
Journal:  Anat Rec (Hoboken)       Date:  2014-01-30       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.